High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2

Heterologous polyclonal antibodies might represent an alternative to the use of convalescent plasma or monoclonal antibodies (mAbs) in coronavirus disease (COVID‐19) by targeting multiple antigen epitopes. However, heterologous antibodies trigger human natural xenogeneic antibody responses particula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Immunol
Main Authors: Vanhove, Bernard, Duvaux, Odile, Rousse, Juliette, Royer, Pierre‐Joseph, Evanno, Gwénaëlle, Ciron, Carine, Lheriteau, Elsa, Vacher, Laurent, Gervois, Nadine, Oger, Romain, Jacques, Yannick, Conchon, Sophie, Salama, Apolline, Duchi, Roberto, Lagutina, Irina, Perota, Andrea, Delahaut, Philippe, Ledure, Matthieu, Paulus, Melody, So, Ray T., Mok, Chris Ka‐Pun, Bruzzone, Roberto, Bouillet, Marc, Brouard, Sophie, Cozzi, Emanuele, Galli, Cesare, Blanchard, Dominique, Bach, Jean‐Marie, Soulillou, Jean‐Paul
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Immunity to infection
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014652/
https://ncbi.nlm.nih.gov/pubmed/33576494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.202049072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados